Ocular immunology and inflammation · 2026
Acute Retinal Necrosis Presenting with Exudative Retinal Detachment: Clinical Features and Outcomes.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Watane Arjun, Nasir Shabtab, Basu Soumyava, Kelgaonkar Anup, Tyagi Mudit
Аннотация
PURPOSE: To analyze the clinical characteristics and outcomes of patients presenting with an exudative retinal detachment (ERD) in Acute Retinal Necrosis (ARN).
METHODS: Retrospective, observational review of cases of ARN with exudative retinal detachment (ERD) that presented to tertiary eye care institutes in Southern and Eastern India between 2015 and 2024.
RESULTS: Clinical records of 322 cases of ARN were reviewed. ERD was noted in 21 eyes of 14 patients (4.34%). ARN involved all the four quadrants in 18 eyes (90%) and three quadrants in 2 eyes (10%). Seven patients had bilateral ARN at the time of initial presentation. Presenting clinical features included occlusive vasculitis in 18 eyes (90%), marked vitritis in 7 eyes (35%), disc edema in 5 eyes (25%). Initial therapy included intravenous (IV) acyclovir in 12 patients (92.3%), IV methylprednisolone in 8 patients (61.5%), and intravitreal ganciclovir in 9 eyes (45%). All the patients were also treated with oral steroids and concomitant systemic antivirals. ERD was seen to resolve in all patients in mean duration of 11.45 ± 4.78 days. 10 eyes (50%) subsequently also developed a rhegmatogenous retinal detachment (RRD). Optic atrophy was seen in 5 eyes (25%), and hypotony in 4 eyes (20%).
CONCLUSION: ERDs, while rare, are important findings in patients with ARN and are a sign of extensive disease activity and extreme inflammation. Eyes with ERD have a higher incidence of occlusive vasculitis and more severe quadrantic involvement.
METHODS: Retrospective, observational review of cases of ARN with exudative retinal detachment (ERD) that presented to tertiary eye care institutes in Southern and Eastern India between 2015 and 2024.
RESULTS: Clinical records of 322 cases of ARN were reviewed. ERD was noted in 21 eyes of 14 patients (4.34%). ARN involved all the four quadrants in 18 eyes (90%) and three quadrants in 2 eyes (10%). Seven patients had bilateral ARN at the time of initial presentation. Presenting clinical features included occlusive vasculitis in 18 eyes (90%), marked vitritis in 7 eyes (35%), disc edema in 5 eyes (25%). Initial therapy included intravenous (IV) acyclovir in 12 patients (92.3%), IV methylprednisolone in 8 patients (61.5%), and intravitreal ganciclovir in 9 eyes (45%). All the patients were also treated with oral steroids and concomitant systemic antivirals. ERD was seen to resolve in all patients in mean duration of 11.45 ± 4.78 days. 10 eyes (50%) subsequently also developed a rhegmatogenous retinal detachment (RRD). Optic atrophy was seen in 5 eyes (25%), and hypotony in 4 eyes (20%).
CONCLUSION: ERDs, while rare, are important findings in patients with ARN and are a sign of extensive disease activity and extreme inflammation. Eyes with ERD have a higher incidence of occlusive vasculitis and more severe quadrantic involvement.
Предметные рубрики MeSH
HumansRetinal DetachmentRetinal Necrosis Syndrome, AcuteRetrospective StudiesMaleFemaleMiddle AgedAntiviral AgentsVisual AcuityAdultAcyclovirGlucocorticoidsFluorescein AngiographyEye Infections, ViralGanciclovirMethylprednisoloneExudates and TransudatesAgedIntravitreal InjectionsYoung AdultTomography, Optical Coherence